| abstract |
COMPOUND INHIBITOR OF THE INTERACTION BETWEEN MDM2 AND P53, PHARMACEUTICAL COMPOSITION, PROCESS TO PREPARE THE REFERRED PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUND, COMBINATION, AND PROCESS TO PREPARE THE COMPOUND. The present invention relates to compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I) in which n, m, p, s, t , R ^ 1 ^, R ^ 2 ^, A and Z have definite meanings. |